Haemonetics (HAE) Net Cash Flow (2009 - 2026)

Haemonetics has reported Net Cash Flow for 18 years, with the latest figure at -$21.4 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 18.8% year-over-year to -$21.4 million in Q2 2026; TTM through Jun 2026 was -$68.2 million, a 20.73% decrease from a year earlier, with the FY2026 full-year figure at -$64.8 million, down 150.36% from the prior year.
• Net Cash Flow was -$21.4 million for Q2 2026 at Haemonetics, up from -$117.2 million in the prior quarter.
• The five-year high for Net Cash Flow was $167.1 million in Q2 2024, with the low at -$160.0 million in Q4 2023.
• Average Net Cash Flow over 5 years is $2.0 million, with a median of $3.2 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow plunged 635.35% in 2023, then soared 5077.38% in 2024.
• Over 5 years, Net Cash Flow stood at -$21.8 million in 2022, then slumped by 635.35% to -$160.0 million in 2023, then jumped by 117.35% to $27.8 million in 2024, then soared by 138.1% to $66.1 million in 2025, then tumbled by 132.42% to -$21.4 million in 2026.
• The last three Net Cash Flow figures came in at -$21.4 million (Q2 2026), -$117.2 million (Q1 2026), and $66.1 million (Q4 2025), per Business Quant data.